Dual Antiplatelet Therapy in Coronary Artery Disease
Abstract Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstra...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Adis, Springer Healthcare
2020-08-01
|
| Saila: | Cardiology and Therapy |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1007/s40119-020-00197-0 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|